Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Sirtuins Family- Recent Development as a Drug Target for Aging, Metabolism, and Age Related Diseases

Author(s): Chiranjib Chakraborty and George Priya Doss. C

Volume 14, Issue 6, 2013

Page: [666 - 675] Pages: 10

DOI: 10.2174/1389450111314060008

Price: $65

Abstract

Silent information regulator 2 (Sir2) proteins, or sirtuins, are a family of proteins which influence several physiological responses and have implications for treating diseases of ageing. In this context, we have presented a summarized view on the discovery of Sir2 family proteins, the enzymatic activities, the role of sirtuins in aging, lifespan and onset of age-related symptoms. In addition, we have described the roles of mammalian sirtuins-with particular emphasis on their associations to aging, metabolism, and age related diseases with recent references. Current findings provide an understanding about mammalian sirtuins and their target diseases, small molecules discovery or drug discovery targeting sirtuin to tackle the serious diseases of aging.

Keywords: Aging, age related diseases, drug target, metabolism, sirtuins.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy